GM-CSF/sargramostim, a drug that improved memory in Alzheimer’s patients during a phase II clinical trial, also appears to improve cognitive function in older adults and those with Down syndrome.
Please follow and like us:
[Read full article of any RSS News at initial Source by clicking through on image or links as available]